Clinical Trials Logo

Clinical Trial Summary

Painful Diabetic peripheral Neuropathy Study of Chinese OutPatiEnt (PDN-SCOPE): a multi-center cross-sectional registry study of clinical characteristics and treatment survey of PDN in China


Clinical Trial Description

Painful diabetic peripheral neuropathy (PDN) presents a serious health problem in China. SCOPE is a cross-sectional, multi-centers registry study with a target sample size of 1500 patients who are experiencing PDN. The patients are treated following guideline and local practice. Real-world data including demographics, medical histories, VAS, PHQ, GAD -7 and therapies are collected. The primary objective is to analyze the clinical characteristics of PDN. The secondary objectives include anxiety depression distribution and current treatment status.The SCOPE study will help to find actual clinical manifestation and treatment and improve the overall treatment outcome of Chinese patients with PDN. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03520608
Study type Observational
Source Peking University Third Hospital
Contact Dongsheng Fan
Phone +8601082265024
Email dsfan@sina.com
Status Recruiting
Phase
Start date May 1, 2018
Completion date May 1, 2019